Alicia O'Neill - GSK | LinkedIn (2024)

Table of Contents
Sign in to view Alicia’s full profile Welcome back Naples, Florida, United States 2K followers 500+ connections View mutual connections with Alicia Welcome back Websites About Welcome back Articles by Alicia FRONTIERS IN MYELOMA: Pioneering solutions to remove the barriers that are standing in the way of progress for Myeloma patients Cancer Sucks! But Jeanie Rocks! "Your work matters. You give me life. Thank you"​. Wow. She didn't expect to be at her daughter's wedding... The Right Track - 4 Steps patients need to take when they hear the words "You Have Cancer"​ What the WSJ article missed: It is the profound and powerful experience that is at the core of what we do - and why we raise so much MOVING MOUNTAINS FOR MULTIPLE MYELOMA - EVEREST BASE CAMP 2018 GOING TO THE ENDS OF THE EARTH – TO FIND A CURE Making Miracles VISION & PURPOSE Activity Thank you, Reuters, for the opportunity to speak on such an important panel at #REPatientUSA. It was a pleasure to reconnect with this incredible… I’m happy to share that I’ve joined the Board of Directors for the Marco Island Center for the Arts. It's a great organization that that fosters… Today, I was delighted to moderate a thoughtful discussion between the Prime Minister Keir Starmer and Eric Schmidt, former CEO of Google on several… Experience & Education GSK ******** ******* ******** ********** - **** ****** ******** ********** ** ******** ********** ********** ** **********, *** ******* View Alicia’s full experience See their title, tenure and more. Welcome back Licenses & Certifications Recorded Drug Development Immersion Certificate of Completion: Fundamentals of Immunology The Biology Of Biotech BioBasics Two-Day Executive Training on the Biotechnology Industry for Non-Scientists Introduction to the Biology of Cancer Volunteer Experience Board of Directors, Development Publications Fewer Participants, More Revenue: A Reverse Model for P2P Honors & Awards Moving Mountains for Multiple Myeloma wins "Most Valuable Pharma Collaboration" Award Winner: Most Valuable Pharma Collaboration Languages Conversational Spanish Organizations Engage for Good Peer 2 Peer Professional Forum Recommendations received More activity by Alicia What an incredible night at the Empower ball on Saturday. A huge congratulations to our inspiring winners who embody strength, resilience, and hope!… View Alicia’s full profile Sign in Other similar profiles Explore more posts Explore collaborative articles Others named Alicia O'Neill in United States Add new skills with these courses

Alicia O'Neill - GSK | LinkedIn (1)

Alicia O'Neill - GSK | LinkedIn (2)

Sign in to view Alicia’s full profile

Welcome back

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

New to LinkedIn? Join now

or

New to LinkedIn? Join now

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Naples, Florida, United States

2K followers 500+ connections

Alicia O'Neill - GSK | LinkedIn (3) Alicia O'Neill - GSK | LinkedIn (4) Alicia O'Neill - GSK | LinkedIn (5)

Alicia O'Neill - GSK | LinkedIn (6)

View mutual connections with Alicia

Welcome back

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

New to LinkedIn? Join now

or

New to LinkedIn? Join now

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Join to view profile

GSK

University of Southern California

Websites

Company Website
http://www.themmrf.org
Company Website
http://www.themmrf.org/now
  • Report this profile

About

Experienced pharmaceutical and business expert who is practices “Patient Driven Science”,…

Welcome back

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

New to LinkedIn? Join now

Articles by Alicia

  • FRONTIERS IN MYELOMA: Pioneering solutions to remove the barriers that are standing in the way of progress for Myeloma patients

    Alicia O'Neill - GSK | LinkedIn (11)

    Jun 12, 2022

    FRONTIERS IN MYELOMA: Pioneering solutions to remove the barriers that are standing in the way of progress for Myeloma patients

    In 2022, the European Hematology Association (EHA) celebrates 30 years of innovation and progress for blood cancers and…

    Alicia O'Neill - GSK | LinkedIn (12) Alicia O'Neill - GSK | LinkedIn (13) Alicia O'Neill - GSK | LinkedIn (14) 61

    7 Comments

  • Cancer Sucks! But Jeanie Rocks!

    Alicia O'Neill - GSK | LinkedIn (15)

    May 23, 2021

    Cancer Sucks! But Jeanie Rocks!

    (Since I am not able to join Jeanie's Celebration of Life in NH today, I wanted to share some of my thoughts here) I…

    Alicia O'Neill - GSK | LinkedIn (16) Alicia O'Neill - GSK | LinkedIn (17) Alicia O'Neill - GSK | LinkedIn (18) 67

    10 Comments

  • "Your work matters. You give me life. Thank you"​. Wow.

    Alicia O'Neill - GSK | LinkedIn (19)

    Sep 11, 2019

    "Your work matters. You give me life. Thank you"​. Wow.

    Yesterday was one of the most moving and powerful days in my career. I had the honor and privilege of bringing a…

    Alicia O'Neill - GSK | LinkedIn (20) Alicia O'Neill - GSK | LinkedIn (21) Alicia O'Neill - GSK | LinkedIn (22) 90

    11 Comments

  • She didn't expect to be at her daughter's wedding...

    Alicia O'Neill - GSK | LinkedIn (23)

    Sep 3, 2019

    She didn't expect to be at her daughter's wedding...

    I attended a wedding yesterday. It was a joyous occasion to be sure.

    Alicia O'Neill - GSK | LinkedIn (24) Alicia O'Neill - GSK | LinkedIn (25) 27

    4 Comments

  • The Right Track - 4 Steps patients need to take when they hear the words "You Have Cancer"​

    Alicia O'Neill - GSK | LinkedIn (26)

    Jun 28, 2019

    The Right Track - 4 Steps patients need to take when they hear the words "You Have Cancer"​

    Cancer is overwhelming. Which is why the MMRF keeps it simple.

    Alicia O'Neill - GSK | LinkedIn (27) 1

  • What the WSJ article missed: It is the profound and powerful experience that is at the core of what we do - and why we raise so much

    Alicia O'Neill - GSK | LinkedIn (28)

    Aug 19, 2018

    What the WSJ article missed: It is the profound and powerful experience that is at the core of what we do - and why we raise so much

    I was interviewed recently for an article in the Wall Street Journal, titled “They’ll Donate More to Charity if You Try…

    Alicia O'Neill - GSK | LinkedIn (29) 12

    3 Comments

  • MOVING MOUNTAINS FOR MULTIPLE MYELOMA - EVEREST BASE CAMP 2018

    Alicia O'Neill - GSK | LinkedIn (30)

    Jun 18, 2018

    MOVING MOUNTAINS FOR MULTIPLE MYELOMA - EVEREST BASE CAMP 2018

    You won't want to miss this inspiring video: https://www.youtube.

    Alicia O'Neill - GSK | LinkedIn (31) 37

    1 Comment

  • GOING TO THE ENDS OF THE EARTH – TO FIND A CURE

    Alicia O'Neill - GSK | LinkedIn (32)

    May 30, 2018

    GOING TO THE ENDS OF THE EARTH – TO FIND A CURE

    Dr. Saad Usmani, a renown myeloma doctor who leads the myeloma team at the Levine Cancer Center in Charlotte, North…

    Alicia O'Neill - GSK | LinkedIn (33) 19

  • Making Miracles

    Alicia O'Neill - GSK | LinkedIn (34)

    Dec 8, 2017

    Making Miracles

    This post, originally from September 2017, is worth re-reading. Inspiring! Spoiler Alert: After 15 years, Carmen's…

  • Alicia O'Neill - GSK | LinkedIn (36)

    Sep 29, 2017

    VISION & PURPOSE

    From September 5, 2017 Today, our second day of the Road to Victories cross country cycling tour to raise funds for the…

    Alicia O'Neill - GSK | LinkedIn (37) 5

See all articles

Activity

  • Thank you, Reuters, for the opportunity to speak on such an important panel at #REPatientUSA. It was a pleasure to reconnect with this incredible…

    Alicia O'Neill - GSK | LinkedIn (38)

    Thank you, Reuters, for the opportunity to speak on such an important panel at #REPatientUSA. It was a pleasure to reconnect with this incredible…

    Liked by Alicia O'Neill

  • I’m happy to share that I’ve joined the Board of Directors for the Marco Island Center for the Arts. It's a great organization that that fosters…

    Alicia O'Neill - GSK | LinkedIn (39)

    I’m happy to share that I’ve joined the Board of Directors for the Marco Island Center for the Arts. It's a great organization that that fosters…

    Shared by Alicia O'Neill

  • Today, I was delighted to moderate a thoughtful discussion between the Prime Minister Keir Starmer and Eric Schmidt, former CEO of Google on several…

    Alicia O'Neill - GSK | LinkedIn (40)

    Today, I was delighted to moderate a thoughtful discussion between the Prime Minister Keir Starmer and Eric Schmidt, former CEO of Google on several…

    Liked by Alicia O'Neill

Join now to see all activity

Experience & Education

  • Alicia O'Neill - GSK | LinkedIn (41)

    GSK

    ********, ******* **********, ********

  • Alicia O'Neill - GSK | LinkedIn (42)

    ******** ******* ******** ********** - ****

    ********, ******** ***********/******** *********

  • Alicia O'Neill - GSK | LinkedIn (43)

    ****** ********

    ***** *** - ***** *****, ****** ******** ******** ******* ********

  • Alicia O'Neill - GSK | LinkedIn (44)

    ********** ** ******** **********

    **, *** ********* ****** ** ************** ************* **********

    -

  • Alicia O'Neill - GSK | LinkedIn (45)

    ********** ** **********, *** *******

    ** ************* *******

    -

View Alicia’s full experience

See their title, tenure and more.

Welcome back

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

New to LinkedIn? Join now

or

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

Licenses & Certifications

Volunteer Experience

  • Board of Directors, Development

    Marco Island Center for the Arts

    - Present 5 months

    Arts and Culture

    I'm happy to bring my business and strategic skill set to this vibrant and inclusive arts nonprofit that fosters creativity, enriches lives, and unites the community through fine and performing arts,

Publications

  • Fewer Participants, More Revenue: A Reverse Model for P2P

    Peer to Peer Professional Forum

    See publication

Honors & Awards

  • Moving Mountains for Multiple Myeloma wins "Most Valuable Pharma Collaboration" Award

    eyeforpharma

    This award recognized the best example of a pharma collaboration in 2017 in North America. Moving Mountains for Multiple Myeloma, a partnership between Takeda, CURE Magazine and the Multiple Myeloma Research Foundation was one of 6 finalists. The panel of 7 judges were from industry, and other non-profits. The :30 second video from our Grand Canyon climb showcases the partnership well: https://www.youtube.com/watch?v=AQ5o1k-vlMs

  • Winner: Most Valuable Pharma Collaboration

    EyeForPharma

    “The eyeforpharma Awards recognize what really matters in the pharmaceutical industry: providing the maximum value to the greatest number of patients. This unique event galvanizes our industry, propelling it in the right direction. I encourage companies and leaders to support and enter – and, just as urgently, to applaud our colleagues who are shining a positive light on the industry as a r esult of the work they do.”

    Moving Mountains for Multiple Myeloma is a collaboration between…

    “The eyeforpharma Awards recognize what really matters in the pharmaceutical industry: providing the maximum value to the greatest number of patients. This unique event galvanizes our industry, propelling it in the right direction. I encourage companies and leaders to support and enter – and, just as urgently, to applaud our colleagues who are shining a positive light on the industry as a r esult of the work they do.”

    Moving Mountains for Multiple Myeloma is a collaboration between Takeda Oncology, Cure Magazine and the MMRF.

    Judge's Comment — "A true collaboration between Patient Group, Industry and Media that raised greater than $1M for Multiple Myeloma research while providing hope and inspiration for impacted patients." Chris Sellin, Head of Operational Excellence & Analytics, Shire

    Judge's Comment — "This project is a powerful reminder that together we can move (in this case 'climb') mountains!" Jill Donahue, Author, EngageRx

Languages

  • Conversational Spanish

    -

Organizations

  • Engage for Good

    Active member

    - Present

    Engage For Good, formerly the Cause Marketing Forum, provides a platform for building successful corporate/cause alliances as well as access to best practices for corporate partnerships and sponsorships in the non-profit sector.

  • Peer 2 Peer Professional Forum

    Active member

    - Present

    Formerly called Run-Walk-Ride Fundraising Council, the P2P Professional Forum professional forum is a national and international organization which brings together thought leaders and KOLs to share best practices, strategies and tactics to create successful peer-to-peer fundraising programs. Alicia was featured on 10/15/13 in the Run Walk Ride Fundraising Council's P2P Spotlight for her outstanding work on behalf of MMRF. See:…

    Formerly called Run-Walk-Ride Fundraising Council, the P2P Professional Forum professional forum is a national and international organization which brings together thought leaders and KOLs to share best practices, strategies and tactics to create successful peer-to-peer fundraising programs. Alicia was featured on 10/15/13 in the Run Walk Ride Fundraising Council's P2P Spotlight for her outstanding work on behalf of MMRF. See: http://www.justmeans.com/multimedia-with-summary/alicia-oneill-director-of-endurance-and-race-events-at-the-multiple-myeloma

Recommendations received

  • Shantanu Ganguly “I have had the opportunity to work closely with Alicia in her role as the Global Patient Advocacy to Outcomes Lead for GSK Hematology. The sheer diversity of Alicia’s experience provides tremendous credibility to her work as a patient advocate builder. Her deep patient insights are highly valued by the leadership and are always seen as crucial inputs for cross-functional stakeholders. Her conviction to bring the patient voice at the center of all we do is infectious and her ‘leadership with a human touch’ inspires all who work with her. Alicia is down-to-earth and a smart strategic thinker, which explains the strong relationships she has forged over the years across patients, doctors and various organizations in the biopharma industry. It has been an absolute pleasure to work with Alicia.”
  • Shawn L. Goodman “It has been a great pleasure of mine to work with Alicia over the course of several years at Millennium: The Takeda Oncology Company, (now Takeda Oncology). She’s led teams of individuals to conceptualize, launch and strategically evolve multiple awareness initiatives for Takeda in combination with the MMRF and other partnering advocacy groups. Most of the programs we created together have successfully spanned across the globe touching individuals in many cultures and geographies. Alicia is an expert in the field of myeloma and is highly respected throughout the community – she is truly a partner of choice across industry and academia. ”

10 people have recommended Alicia

Join now to view

More activity by Alicia

  • What an incredible night at the Empower ball on Saturday. A huge congratulations to our inspiring winners who embody strength, resilience, and hope!…

    Alicia O'Neill - GSK | LinkedIn (58)

    What an incredible night at the Empower ball on Saturday. A huge congratulations to our inspiring winners who embody strength, resilience, and hope!…

    Liked by Alicia O'Neill

View Alicia’s full profile

  • See who you know in common
  • Get introduced
  • Contact Alicia directly
Join to view full profile

Sign in

Stay updated on your professional world

Sign in

By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.

New to LinkedIn? Join now

Other similar profiles

  • Zsuzsanna Devecseri MD, MBA Cambridge, MA Connect
  • Karen Frascello Cambridge, MA Connect
  • Diaa Diab Boston, MA Connect
  • Eduardo Sabaté Basking Ridge, NJ Connect
  • Abbey Curran Greater Chicago Area Connect
  • Jennifer M. Barrett, MSc New York City Metropolitan Area Connect
  • Jay Rule Novartis' One Health Studios New York City Metropolitan Area Connect
  • Sandra Casiano Greater Boston Connect
  • Michael Glover Greater Philadelphia Connect
  • Reed S Oxman MD, FACEP Open to New Opportunities, Medical Director Insurance, Medical Devices Greater Philadelphia Connect

Explore more posts

  • Dan Schell Everyone is talking about the new FDA Guidance on diversity in #clinicaltrials. Here, Denise N. Bronner, Ph.D., breaks down what's good AND bad about the new guidance. https://lnkd.in/gTcTpg9T #diversityinclinicaltrials #clinicaltrialdiversity 8
  • Naweed Muhammad 🧓👵👴Long-Term Care Gets a Tech Boost: How New Advancements Benefit Seniors and Pharmacists?Here at TIB Pharmacy, we're passionate about empowering our patients to live healthy, independent lives. That's why I'm thrilled about the recent surge in technology designed to support seniors in long-term care facilities and even at home.As your pharmacist, I've seen firsthand how these advancements can benefit patients:**Improved Medication Adherence: Medication reminders and easy video calls with caregivers can significantly improve medication adherence, reducing complications and potentially lowering the need for additional prescriptions.**Early Detection of Health Concerns: Wearable health trackers can monitor vitals and activity levels, allowing for earlier detection of potential health issues. This means faster intervention and potentially fewer medication adjustments due to missed symptoms.**Promoting Independence: Technology like GPS trackers and video calls empowers seniors to manage their daily lives at home, reducing feelings of isolation and potentially decreasing the need for certain medications used to manage those conditions.Here's how I can help:**Educating Patients and Families: I'm happy to discuss these advancements with you and your loved ones, exploring how they can improve well-being and potentially reduce medication-related issues.**Partnering with LTC Facilities: Collaboration with LTC facilities ensures residents receive the medications they need while seamlessly integrating these new technologies.**Staying Current on the Latest Tech: The world of senior care technology is constantly evolving. I'm committed to staying up-to-date to best serve my patients.Technology is transforming long-term care, and at TIB Pharmacy, we're excited to be part of it.Let's work together to create a future where seniors can enjoy a higher quality of life with greater independence and better health outcomes.Let us know your thoughts about this, feel free to share it in the comments section!Call us!TIB PharmacyT: (510)-573-0064A: 5886 Mowry School Rd, Newark CA, 94560#LongTermCare #MedicationManagement #BetterHealth #Teamwork #TIBPharmacy #NewarkPharmacy #pharmacyservices #longtermcare #LTCPharmacy #HospicePharmacy #EndOfLifeCare #hospicespecialized #ltcspecialized #ltcathome #enteraltherapy#MedicationManagement #PackagingPower #SimplifyYourHealthhttps://lnkd.in/gUWj3PGp 3 1 Comment
  • PlansConnect, LLC Great article shared today on a zoom call with other women physicians in pharma: https://lnkd.in/efhcNaxGThank you Carolyn Kay, MD (she/her) for your insightful comments on the call today with Swati S. and others!#womenshealth #physiciansinpharma #womenwholead #harvardbusinessreview 2
  • Dan Sfera 🌟 How do you turn burnout into breakthrough? Our latest video with Elizabeth Tabor features an inspiring journey from chaos to community-building success: transitioning from a relentless work grind to founding the Clinical Research Referral Club!Here's what we learned:- Recharge first. Overcoming burnout is crucial before any new venture.- Nurture your network. Don’t let your connections fade away.- Spark the idea. Sometimes, a simple realization can kickstart an impactful initiative.- Act fast. A quick flyer led to 200 sign-ups in just one hour!Curious about starting your own community? What’s your story of turning burnout into opportunity? Share your thoughts below! ⬇️#CareerGrowth #Networking #Entrepreneurship #Productivity #BurnoutRecovery #ClinicalResearch 12 2 Comments
  • Karin Hoelzer
  • Stephanie M. Clark, MS What did I learn from serving as a poll worker for election duty on May 14th? 1. Our democracy needs its citizens to contribute by working our elections to ensure free and fair elections. 2. My poll worker colleagues and I happily greeted and bid goodbye to everyone, regardless of whether they were a Republican, Democrat, or Non-Partisan, because we are all Americans. 3. In Nebraska, your identification is checked twice: once when you enter the polling area and again at the table. Don't put that ID away yet! 4. The poll workers did not decide on the ID law, so don't take it out on the poll workers if you disagree with it. 5. You cannot wear partisan buttons, signs, t-shirts etc. into the polling place. Please leave these at home. 6. We had around 250 citizens vote at our polling location yesterday (during the hours of 7 AM to 8 PM), and our location had more traffic than most. 7. Most people thanked us for serving election duty. It was a nice surprise. 8. If you did not receive a card in the mail confirming your polling place, check it before you go to vote. For some, polling locations for Omaha have changed, regardless of whether you voted at the same location for several years. Double-check so as not to waste your time. 9. If your son or daughter no longer lives with you but is listed on our roster, he/she/they will need to change their address with the election office. 10. If you requested an absentee ballot but show up at the polling place, you will be asked to use a provisional ballot. It's best to use the absentee ballot you were originally sent and drop it at an official election box location. We cannot take absentee ballots at the polling site. Make sure to vote! 10
  • Eric Racine, PharmD, MBA The intersection of advocacy, philanthropy, and business creates powerful opportunities to accelerate innovation for patients.​​Not many have a better insight into this space than David Panzirer, a Trustee at The Helmsley Charitable Trust and one of the most significant leaders in the field of venture philanthropy.​​In a new episode of Patient Advocacy Voices, my co-host Andrew Vilcinskas – a type 1 diabetes (T1D) patient himself – and I had a great conversation with David to get an understanding of his unique approach. David and his team continuously assess the healthcare ecosystem to develop a deep understanding that guides their investment decisions. He takes a portfolio approach to healthcare investments and is driven by a singular focus – improving the lives of people living with T1D.​​This episode is a must-listen for anyone interested in getting the most return from their philanthropic investments by applying a business mindset.​​➡️Check out the latest episode and let me know how you prioritize to deliver impact for patients. https://lnkd.in/esv2kjNf David Panzirer Andrew Vilcinskas Angie Bricco Olivier Bogillot Nadia Fontaine Mattias Wieloch​#Healthcare #PatientAdvocacy #Diabetes #T1D 66 4 Comments
  • Dr. Timos Papagatsias Thoughts on this? >> Scorpion raises $150M for next wave of targeted cancertherapies >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #biotech #productmarketing #pharmaceutical
  • Judith Orvos, ELS From ages 40 to 74 years, #mammography is now recommended every other year for women at average risk of #breastcancer. #USPSTF #breastcancerscreening Full report at https://lnkd.in/eZETdbR6 2
  • Dr. Timos Papagatsias Thoughts on this? >> Groundbreaking gene therapy trial restores toddler's hearing- USA TODAY >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #biotech #competitivemarketing
  • Tim Crum PharmD, BCGP Not an uncommon experience with #insurance and #priorauthorization. Think about the steps to a #specialty mail order medication:Day 1:1. Doctor writes prescription and sends to patient's preferred pharmacy.2. The insurance rejects the claim and directs the patient to a "specialty" pharmacy.Day 2-3:3. Patient tries to get prescription transferred (if electronic or verbal) to specialty pharmacy or mails hardcopy. 3b. Patient chooses instead to call doctor and ask for a new prescription to be sent to the specialty pharmacy.Day 3-5:4. Doctor sends prescription #2 to the specialty pharmacy.5. Prescription rejects for prior authorization. (It's now at the "right" pharmacy, but the formulary requires a review by the insurance).6. The pharmacy contacts doctor and informs patient.Day 5-8:7. After much back and forth, PA forms, missing information, clarifications, follow up calls by the patient to the doctor and insurance, by the doctor to the insurance, and by the patient to the pharmacy, an approval is granted.8. Because the member has a plan with a deductible that is not met, their cost-share for the approved medication is $1000+.Day 9-10: 9. Patient receives medication in the mail.10 days is being generous. Many patients get lost in the shuffle, may wait until their next doctor appt, or never get the prescription at all. Little did the patient know they could have just paid $80 cash at their original pharmacy without a prior authorization. The patient would have received the medication on Day 1 at their preferred pharmacy at a fraction of the cost.The numbers used are for representative purposes only and may sound like an egregious variance, but it exists. Seeing many examples throughout my career serve as motivation to do something about it.#getgreenback #greenbackhealth #pricemymeds 9 3 Comments
  • Sam Barnes Is personalization in #omnichannel #medicalaffairs #communications possible?How would you even approach that utopia? Hear what our team has to say about this in our new white paper. 3
  • Tom Lo, MS, MBA Access to physicians can be challenging, so it's crucial to focus efforts on reaching those who can truly impact revenue. Quality data is key to driving effectiveness. Commercial alerts provide a solution to connect with the right physicians at the right time with the right messaging. #salesforceeffectiveness #pharmamarketing #raredisease #omnichannel 10
  • Naweed Muhammad Dementia Care: Keeping Loved Ones Safe and Happy at HomeWith 5.8 million people in the U.S. living with dementia, many remain at home throughout their illness. While this can be a personal choice or the most affordable option, it comes with unique challenges.Key Tips for Effective Home Care:Understand and Accept the DiagnosisLearn about dementia and connect with support organizations to navigate the journey. Acceptance can make caregiving easier and improve quality of life.Enhance Home SafetyInstall grab bars, secure carpets, and lock away dangerous items to prevent accidents. Over 90% of dementia-related needs are safety-related.Prioritize Self-CareCaregiving can be overwhelming. Schedule regular breaks, seek help from family, and find self-care practices to recharge and avoid burnout.Support and resources are available to help you manage the complexities of dementia care and keep both you and your loved one safe and happy at home.Visit www.tibpharmacy.com or call (510)-573-0064 to learn more about how we can support your well-being. Let's journey towards better health together! #TIBPharmacy #HealthAsWeAge #Multivitamins #NutritionForSeniors #LongTermCare #MedicationManagement #BetterHealth #Teamwork #TIBPharmacy #NewarkPharmacy #pharmacyservices #longtermcare #LTCPharmacyEndOfLifeCare #ltcathome #hospicespecialized #LTCPharmacy #HospicePharmacy #ltcspecialized #MedicationManagement #PackagingPower #SimplifyYourHealth #health #wellness 6 2 Comments
  • CRA on Rare Disease #CRALifeSciences consultants recently conducted one of the largest surveys of Persons Living with a Rare Disease (PLWRD) and their caregivers, led by Tim Wilsdon, Kirsten Axelsen, Rajini Yamuna Jayasuriya, and Charlotte Poon. The study focused on the economic impact of 43 rare diseases across nine European countries, estimating costs related to healthcare, work productivity, as well as health-related quality of life. The findings highlight the significant financial burden on PLWRDs and society, underscoring the need for urgent action by policymakers to address this major public health challenge. To learn more about their findings and read the full report, click here: https://crai.news/5sp 24
  • Dr. Timos Papagatsias Thoughts on this? >> Neurogene rethinks gene therapy trial after high dose leavesRett patient in critical condition >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #competitivemarketing #biotech #pharma #pharmaceutical 4
  • Dr. Timos Papagatsias Thoughts on this? >> Synapticure raises $25M for neurodegenerative diseaseapproach >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #healthcare #biotech #pharmaceutical
  • Diakonos Oncology Diakonos Oncologyannounces that theU.S. FDAhas granted Fast Track designation for the company’sunique dendritic cell vaccine (DCV) for pancreatic ductal adenocarcinoma.In addition, we are proud to announce that wehave named to our Scientific Advisory Board,Daniel D. Von Hoff, M.D., Distinguished Professor at the Translational Genomics Research Institute (TGen) in Phoenix, AZ, and City of Hope, and an experienced investigator against pancreatic cancer.“This second FDA Fast Track designation of our autologous dendritic cell vaccines for pancreatic cancer is another acknowledgement of the incredible potential of this innovative immunotherapy for treating the most deadly cancers,” saidMike Wicks,Diakonos CEO. “We are thrilled to have Dr. Von Hoff join us as an advisor as we pursue clinical development of our vaccine in this deadly disease,” added Mr. Wicks. “The first designation was for our lead vaccine for glioblastoma multiforme (GBM) which successfully completed dosing for the Phase 1 trial and has significantly improved 12 month survival in those patients to well over what would be expected with the standard of care.” “Diakonos's unique dendritic cell vaccine has shown encouraging results in treating glioblastoma, a terrible disease with few effective treatments. Pancreatic cancer patients also need additional treatment options," said Dr. Von Hoff. "I look forward to working with Diakonos to help develop effective treatments for patients with pancreatic cancer with the same targeted technology."Diakonos’ dendritic cell vaccines aremade with a patient’s dendritic cells and a sample of their tumor. These highly differentiated double-loaded dendritic cell vaccines activaterobust cytotoxic TH1 cell signaling pathways that initiate a natural immune response to target and eliminate cancer cells. This is achieved without any genetic modification of the patient’s immune cells, which greatly simplifies the manufacturing process and significantly reduces costs when compared to leading cell therapy approaches.Diakonos Oncology is dedicated to revolutionizing cancer immunotherapy and focusing on difficult-to-treat indications, including glioblastoma and PDAC. A variant of the DOC1021 treatment platform are also in early-stage clinical testing in angiosarcoma (AS). For more information visit:www.diakonosoncology.com.#cancerresearch #pancreaticcancer #cancer #biopharmahttps://lnkd.in/gx-GQx-p 40 4 Comments
  • Maria Whitman
  • UpToDate The #HPV vaccine has accumulated significant wins in reducing rates of #cancer mortality. Clinical leaders are perfectly positioned to keep the momentum. Read our Expert Insight to find out how to support National Immunization Awareness Month (NIAM). https://ow.ly/vzEt50SU0iE #UpToDate #NIAM #UpToDateSupportsHealth 1

Alicia O'Neill - GSK | LinkedIn (124)

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Alicia O'Neill in United States

  • Alicia O'Neill Executive Director at JP Morgan Chase New York, NY
  • Alicia O. Experienced Merchant and Client Services Leader | Buying | Product Development | Merchandising New York City Metropolitan Area
  • Alicia ONeill Guerra LLP Greater Houston
  • Alicia O'Neill Experienced Leader in Project and Operational Management Greater Phoenix Area

42 others named Alicia O'Neill in United States are on LinkedIn

See others named Alicia O'Neill

Add new skills with these courses

  • 1h 8m The Data Science of Nonprofit Service Organizations, with Barton Poulson
  • 1h 1m Virtual Events Essential Training
  • 39m Influencer Brand Deals 101

See all courses

Alicia O'Neill - GSK | LinkedIn (2024)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Ray Christiansen

Last Updated:

Views: 6108

Rating: 4.9 / 5 (49 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Ray Christiansen

Birthday: 1998-05-04

Address: Apt. 814 34339 Sauer Islands, Hirtheville, GA 02446-8771

Phone: +337636892828

Job: Lead Hospitality Designer

Hobby: Urban exploration, Tai chi, Lockpicking, Fashion, Gunsmithing, Pottery, Geocaching

Introduction: My name is Ray Christiansen, I am a fair, good, cute, gentle, vast, glamorous, excited person who loves writing and wants to share my knowledge and understanding with you.